Elevance Health (ELV) to reaffirm earnings guidance

Elevance Health (NYSE: ELV) disclosed:

Officers of Elevance Health, Inc. (the “Company”) will speak with investors over the next several weeks. During these meetings, Company officers intend to reaffirm the Company’s shareholders’ earnings guidance for full year 2025 to be $30.40 to $31.10 per diluted share, including approximately $3.75 per diluted share of net unfavorable items. Excluding these items, the Company continues to expect adjusted shareholders’ earnings to be $34.15 to $34.85 per diluted share.

In addition, the Company continues to expect 2025 year-end total medical enrollment to be consistent with the guidance provided in its Fourth Quarter 2024 Earnings Release, dated January 23, 2025, including expectations for Medicare Advantage membership of 2.2 to 2.25 million members.

None of the information furnished in Item 7.01 hereto shall be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings.

You May Also Be Interested In

• Pizza Hut CEO Aaron Powell resigns
• Tencent Music plans senior unsecured notes offering
• EU opens antidumping review of Chinese silicon metal imports